Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 3Neoplasm Metastasis 2Urinary Bladder Neoplasms 1Tracheal Diseases 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Mesothelioma 1Lung Neoplasms 1Laryngeal Diseases 1Hyperparathyroidism, Primary 1Esophageal Neoplasms 1Deglutition Disorders 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Adenoid Cystic 1Adenocarcinoma of Lung 1

Interventions

Cisplatin 41Gemcitabine 25Radiotherapy, Intensity-Modulated 15Fluorouracil 15Radiotherapy 12Docetaxel 10pembrolizumab 8Paclitaxel 8Carboplatin 8Capecitabine 7Oxaliplatin 5toripalimab 4spartalizumab 4Surveys and Questionnaires 4Bevacizumab 4camrelizumab 3Nivolumab 3Induction Chemotherapy 3Immunohistochemistry 3Endostatins 3Counseling 3Cetuximab 3Acupuncture Therapy 3tislelizumab 2sintilimab 2nimotuzumab 2endostar protein 2apatinib 2Taxes 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Neoplasms × Tablets × Head & Neck × Clear all
NCT07042711 2025-06-29

Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients

Indonesia University

Phase NA Active not recruiting
300 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡